Filter posts

Session Summary: What Every CEO Must Know About IP In Biotech

On Sunday, April 21st, 2013, I attended a standing room only session titled, “What Every …

Kirtsaeng v. John Wiley & Sons: No Good Deed Goes Unpunished

The Supreme Court handed Kirtsaeng a victory last week finding his importation and resale of …

Spotlight on India’s Emerging Biotech Sector

India’s biotechnology sector is a burgeoning one, with more than 325 companies and some with …

Prior User Rights and Trade Secrets

By Joe Allen, President, Allen and Associates One theme of the day is the cloud …

Measuring the Impact of Innovation

By Joe Allen, President, Allen and Associates It’s always an indication of interest and importance …

Biotech IP Challenges Around the World: BIO’s Special 301 Submission

BIO recently submitted its Special 301 Submission highlighting intellectual property (IP) challenges around the world.  …

Brazilian Innovation: A Patent Success

The story of Acheflan highlights the role of patents in homegrown innovation in developing countries.  …

Scientific American on BRIC's IP Environment

Scientific American World View issued a special report at this year’s 2011 BIO International Convention …

USTR: TPP to have High IP Standards to "Stand Alongside other Treaty Agreements in the Area"

Stan McCoy, Assisant U.S. Trade Representative for Intellectual Property and Innovation, spoke at BIO’s 2011 …

Counterfeiting: White House IP Czar Victoria Espinel on working with corporations

White house IP Czar Victoria Espinel spoke at BIO’s 2011 International Convention in a session …